DermaDetect

AI-driven Digital Diagnostics for Skin Disorders

Health Tech & Life Sciences
Active
Seed Rehovot, Israel Founded 2016
Last updated 2026-06-18
Total raised
$4.4M
Last: Grant 2022-12
Stage
Seed
Founded
2016
Headcount
8
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences

About

DermaDetect is an AI-driven software that enables remote diagnosis and treatment of skin disorders. Based on intelligent software, the platform integrates easily with existing systems, is easy to use and accessible 24/7, and has an attractive pay-per-usage pricing model. This skin diagnostics capability can be seamlessly integrated into any dermatological disciplines that require skin diagnostics. In addition to DermaDetect, the company has launched DermaAssess and DermaManage, which are based on the same technology, and is currently developing additional products. The company is rolling out its automated skin diagnosis application across the entire Maccabi Health Services network in Israel. DermaDetect's FDA/CE-cleared platform serves more than 2.5 million patients while empowering physicians by augmenting the current clinical workflow and helping them manage the ever-increasing workload without compromising quality of care.

Funding history · 6 rounds · $4.4M total

Q&A

What is DermaDetect's primary focus?
DermaDetect is an AI-driven software company focused on digital diagnostics for skin disorders, enabling remote diagnosis and treatment.
When was DermaDetect founded?
DermaDetect was founded in November 2016.
How many employees does DermaDetect have?
DermaDetect has 1-10 employees.
What is the total amount of funding DermaDetect has raised to date?
DermaDetect has raised a total of $4,352,200 USD.
Which investors participated in DermaDetect's March 2022 funding round?
In March 2022, DermaDetect received funding from Keren Maccabi and Medison Ventures.
What is DermaDetect's current product strategy?
In addition to its core DermaDetect platform, the company has launched DermaAssess and DermaManage, which are based on the same technology, and is developing additional products.
What is the market reach of DermaDetect's platform?
DermaDetect's FDA/CE-cleared platform serves more than 2.5 million patients and is being rolled out across the entire Maccabi Health Services network in Israel.
What was DermaDetect's most recent funding event?
In December 2022, DermaDetect received a Grant of $285,700 USD from the Israel Innovation Authority.

Team · 4

Founder · Co-founder & Board Member
LinkedIn ↗
Founder · Co-founder & Business Development Manager
LinkedIn ↗
Founder · Co-founder & Dermatology Scientific Advisor
Founder · Co-founder (No longer with the company)
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Medical Diagnostics
Technologies
Artificial IntelligenceDeep LearningComputer VisionMachine LearningPlatforms & InterfacesSoftwareMobile
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

digital-healthcaretelemedicinenon-invasiveactionable-insightsdecision-makingdeep-learningmachine-learningdata-analyticsmobile-applicationsdiagnosticsmhealthmedical-devicesartificial-intelligenceskin-caredermatologycomputer-visionhealthcare-providershospitalsmedical-technologiestreatmentshome-caredoctorsoptronics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)